Table 6.
Reported SAEs per million doses for COVID-19 vaccines, Influenza, HPV, Monkeypox vaccines and corresponding relative risks (95% C.I.)
| Total reported SAEs rate | Relative risk | ||||||
|---|---|---|---|---|---|---|---|
| COVID-19 | Influenza | HPV | Monkeypox | RR COVID-19, Influenza | RR COVID-19, HPV | RR COVID-19, Monkeypox | |
| Overall | 96.54 | 4.93 | – | – | 19.60 (18.80, 20.44) | – | – |
| Males | 87.04 | 3.90 | – | – | 22.32 (20.82, 23.93) | – | – |
| Females | 105.30 | 5.77 | – | – | 18.25 (17.32, 19.24) | – | – |
| Adolescents | 60.73 | 2.96 | 14.62 | – | 20.54 (18.03, 23.40) | 4.15 (3.91, 4.41) | – |
| Male adolescents | 81.35 | 2.76 | 5.07 | – | 29.47 (24.41, 35.57) | 16.05 (14.05, 18.33) | – |
| Female adolescents | 40.71 | 3.15 | 20.50 | – | 12.92 (10.76, 15.50) | 1.99 (1.82, 2.16) | – |
| Adults | 101.91 | 5.35 | – | – | 19.05 (18.23, 19.92) | – | – |
| Male adults | 87.92 | 4.18 | – | 11.14 | 21.05 (19.54, 22.70) | – | 7.89 (3.95, 15.78) |
| Female adults | 114.71 | 6.27 | – | – | 18.28 (17.3, 19.32) | – | – |